Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Inhibition of rhinovirus replication in vitro and in vivo by acid-buffered saline.

Gern JE, Mosser AG, Swenson CA, Rennie PJ, England RJ, Shaffer J, Mizoguchi H.

J Infect Dis. 2007 Apr 15;195(8):1137-43. Epub 2007 Mar 9.

PMID:
17357049
2.

Synthesis of the allergen ovomucoid by a replicating Mengo virus.

Amineva SP, Mosser AG, Binder JJ, Aminev AG, Palmenberg AC, Gern JE.

Arch Virol. 2006 Oct;151(10):1933-46. Epub 2006 May 29.

PMID:
16732496
3.

Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues.

Mosser AG, Vrtis R, Burchell L, Lee WM, Dick CR, Weisshaar E, Bock D, Swenson CA, Cornwell RD, Meyer KC, Jarjour NN, Busse WW, Gern JE.

Am J Respir Crit Care Med. 2005 Mar 15;171(6):645-51. Epub 2004 Dec 10.

PMID:
15591468
4.

Attenuated innate mechanisms of interferon-gamma production in rats susceptible to postviral airway dysfunction.

Rosenthal LA, Mikus LD, Tuffaha A, Mosser AG, Sorkness RL, Lemanske RF Jr.

Am J Respir Cell Mol Biol. 2004 May;30(5):702-9. Epub 2003 Oct 30.

PMID:
14592927
5.

Persistence of viral RNA in 2 rat strains differing in susceptibility to postbronchiolitis airway dysfunction.

Sorkness RL, Gern JE, Grindle KA, Mosser AG, Rosenthal LA, Mikus LD, Lemanske RF Jr.

J Allergy Clin Immunol. 2002 Oct;110(4):607-9.

PMID:
12373269
6.

Chronic postbronchiolitis airway instability induced with anti-IFN-gamma antibody in F344 rats.

Sorkness RL, Castleman WL, Mikus LD, Mosser AG, Lemanske RF Jr.

Pediatr Res. 2002 Sep;52(3):382-6.

PMID:
12193672
7.

Interferon-gamma enhances rhinovirus-induced RANTES secretion by airway epithelial cells.

Konno S, Grindle KA, Lee WM, Schroth MK, Mosser AG, Brockman-Schneider RA, Busse WW, Gern JE.

Am J Respir Cell Mol Biol. 2002 May;26(5):594-601.

PMID:
11970912
8.

Similar frequency of rhinovirus-infectible cells in upper and lower airway epithelium.

Mosser AG, Brockman-Schneider R, Amineva S, Burchell L, Sedgwick JB, Busse WW, Gern JE.

J Infect Dis. 2002 Mar 15;185(6):734-43. Epub 2002 Feb 19.

PMID:
11920291
9.

Influence of three-dimensional structure on the immunogenicity of a peptide expressed on the surface of a plant virus.

Taylor KM, Lin T, Porta C, Mosser AG, Giesing HA, Lomonossoff GP, Johnson JE.

J Mol Recognit. 2000 Mar-Apr;13(2):71-82.

PMID:
10822251
10.

Antibody-mediated neutralization of human rhinovirus 14 explored by means of cryoelectron microscopy and X-ray crystallography of virus-Fab complexes.

Che Z, Olson NH, Leippe D, Lee WM, Mosser AG, Rueckert RR, Baker TS, Smith TJ.

J Virol. 1998 Jun;72(6):4610-22.

11.
12.

WIN51711-resistant mutants of poliovirus type 3: capsid residues important in uncoating functions.

Mosser AG, Sgro JY, Rueckert RR.

Acta Crystallogr D Biol Crystallogr. 1995 Jul 1;51(Pt 4):490-5.

PMID:
15299835
13.
14.

Structure determination of an Fab fragment that neutralizes human rhinovirus 14 and analysis of the Fab-virus complex.

Liu H, Smith TJ, Lee WM, Mosser AG, Rueckert RR, Olson NH, Cheng RH, Baker TS.

J Mol Biol. 1994 Jul 8;240(2):127-37.

PMID:
8027997
15.

Use of drug-resistance mutants to identify functional regions in picornavirus capsid proteins.

Mosser AG, Shepard DA, Rueckert RR.

Arch Virol Suppl. 1994;9:111-9.

PMID:
8032243
17.

Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody.

Smith TJ, Olson NH, Cheng RH, Liu H, Chase ES, Lee WM, Leippe DM, Mosser AG, Rueckert RR, Baker TS.

J Virol. 1993 Mar;67(3):1148-58.

18.

Three-dimensional structure of poliovirus serotype 1 neutralizing determinants.

Page GS, Mosser AG, Hogle JM, Filman DJ, Rueckert RR, Chow M.

J Virol. 1988 May;62(5):1781-94.

19.
20.

Structure of a human common cold virus and functional relationship to other picornaviruses.

Rossmann MG, Arnold E, Erickson JW, Frankenberger EA, Griffith JP, Hecht HJ, Johnson JE, Kamer G, Luo M, Mosser AG, et al.

Nature. 1985 Sep 12-18;317(6033):145-53.

PMID:
2993920
21.
24.
25.

Population ecology of Sulfolobus acidocaldarius. I. Temperature strains.

Mosser JB, Mosser AG, Brock TD.

Arch Microbiol. 1974 May 16;97(3):169-79. No abstract available.

PMID:
4847495
26.

Increased concanavalin A-dependent agglutinability of mouse fibroblasts after treatment with leukocyte lysosomal preparations.

Mosser AG, Janoff A, Blondin J.

Cancer Res. 1973 May;33(5):1092-5. No abstract available.

27.

Bacterial origin of sulfuric Acid in geothermal habitats.

Mosser JL, Mosser AG, Brock TD.

Science. 1973 Mar 30;179(4080):1323-4.

PMID:
17835938
28.

Incorporation of lipid precursors into cytoplasmic membranes of poliovirus-infected HeLa cells.

Mosser AG, Caliguiri LA, Tamm I.

Virology. 1972 Jan;47(1):39-47. No abstract available.

PMID:
4333576
29.

Chemical and enzymatic characteristics of cytoplasmic membranes of poliovirus-infected HeLa cells.

Mosser AG, Caliguiri LA, Scheid AS, Tamm I.

Virology. 1972 Jan;47(1):30-8. No abstract available.

PMID:
4333575
30.

Proteins associated with the poliovirus RNA replication complex.

Caliguiri LA, Mosser AG.

Virology. 1971 Nov;46(2):375-86. No abstract available.

PMID:
4331730
31.

Blocking of guanidine action on poliovirus multiplication.

Mosser AG, Caliguiri LA, Tamm I.

Virology. 1971 Sep;45(3):653-63. No abstract available.

PMID:
4331105

Supplemental Content

Loading ...
Support Center